ArticleFrontiers in pharmacology2022

Acquired Concurrent EGFR T790M and Driver Gene Resistance From EGFR-TKIs Hampered Osimertinib Efficacy in Advanced Lung Adenocarcinoma: Case Reports.

Yue Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.